VELOCITY: A GAME CHANGER FOR COMMERCIAL PHARMA’S COMPETITIVE EDGE

OVERVIEW:

In the fiercely competitive world of commercial pharmaceuticals, staying ahead is not just a goal; it's a necessity. Gaining an advantage requires more than just innovative drugs and market expertise—it demands the power of timely artificial intelligence (AI) supported decision making, preservation of analytic capital, and unlocking the full potential of data scientists. VELOCITY, the industry-leading analytic operations as a service platform for pharma, is driving this transformation. In the following article, we'll explore how VELOCITY is ushering in a new era of competitiveness by enabling rapid decision-making, retaining intellectual capital, and freeing up data scientists to focus on developing new insights.

RAPID DECISION MAKING:

Swift and well-informed decisions can mean the difference between seizing an opportunity and missing out. VELOCITY empowers commercial pharma organizations by enabling non-data scientists, typically business analysts, to access and execute AI on-demand. This means that they can provide answers to pressing business questions without waiting for complex data reports or relying solely on data scientists' availability.

VELOCITY enables AI models that work seamlessly with the diverse array of data available including promotional activity, sales data, market trends, and regulatory updates. By providing near-real-time access to these insights, VELOCITY equips analysts, and ultimately decision-makers, with the information necessary to respond rapidly to changing market dynamics. This agility ensures that commercial pharma organizations stay ahead of the curve and capitalize on emerging opportunities.

RETENTION OF INTELLECTUAL CAPITAL:

Pharmaceutical companies accumulate a wealth of intellectual capital over the years, including the advanced analytic models optimized for their brands and markets. Unfortunately, this knowledge often remains scattered and undermanaged. VELOCITY steps in as a solution in preserving these invaluable assets.

In preparing models and data to be automated, best practice standards for understandability, performance, and maintainability are applied. With the standards in place, most data scientists could step in and update or enhance the analytic in short order. VELOCITY ensures that critical information isn't lost when employees leave, fostering knowledge continuity and reducing the risk associated with knowledge gaps.

EMPOWERING DATA SCIENTISTS:

Data scientists are a valuable resource in the pharmaceutical industry, but their expertise is most effective when focused on innovation and new insight development. However, they are often bogged down by routine analytic operations, which limits their capacity to focus on these high-value tasks. 

VELOCITY alleviates this bottleneck by automating AI model operations that used to take up a majority of their time, allowing data scientists to concentrate on developing insights that drive further performance improvements. By streamlining analytic operations, VELOCITY accelerates the pace of discovery and positions data scientists at the forefront of scientific and technological advancements. This enables them to innovate more freely, driving the organization's competitiveness to new heights.

CONCLUSION

In a rapidly evolving commercial pharmaceutical landscape, VELOCITY is more than just a platform—it's a catalyst for competitiveness. By enabling rapid decision-making, preserving intellectual capital, and freeing up data scientists from operational tasks, VELOCITY equips commercial pharma organizations with the agility and decision support needed to thrive. With VELOCITY, innovative leaders can look forward to a future where timely decisions, knowledge preservation, and data science innovation become the norm, giving them the competitive edge they need to excel.

----

SENTIER was founded in 2017 to disrupt analytic insight generation and delivery in Pharma. Through VELOCITY, the industry leading Analytic Operations as a Service (AOaaS) platform, our customers are able to maximize the ROI on AI and ML activities by allowing non-data scientists to deliver answers as frequently as the business demands.  We also support our clients with advanced marketing & sales analytics and support services designed to prepare models and data pipelines for production. SENTIER believes that the ethical application of solutions will benefit patients and health care providers as well as the Pharma and Biotech companies we work with.